{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:35:42Z","timestamp":1793190942800,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejphar.2023.175957","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T10:07:02Z","timestamp":1691057222000},"page":"175957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Platycodin D induces apoptotic cell death through PI3K\/AKT and MAPK\/ERK pathways and synergizes with venetoclax in acute myeloid leukemia"],"prefix":"10.1016","volume":"956","author":[{"given":"Xia","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8676-8859","authenticated-orcid":false,"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175957_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1541-7786.MCR-20-0687","article-title":"The MEK\/ERK network as a therapeutic target in human cancer","volume":"19","author":"Barbosa","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejphar.2023.175957_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/17474086.2021.1875814","article-title":"A review of FDA-approved acute myeloid leukemia therapies beyond '7 + 3'","volume":"14","author":"Bazinet","year":"2021","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.ejphar.2023.175957_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2019.05.025","article-title":"AKT and ERK dual inhibitors: the way forward?","volume":"459","author":"Cao","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2023.175957_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2023.175957_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jcb.24386","article-title":"Platycodin D induces anoikis and caspase-mediated apoptosis via p38 MAPK in AGS human gastric cancer cells","volume":"114","author":"Chun","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2023.175957_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cbi.2013.07.002","article-title":"Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways","volume":"205","author":"Chun","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2023.175957_bib7","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"Dohner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175957_bib8","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","article-title":"Acute myeloid leukaemia","volume":"368","author":"Estey","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2023.175957_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.leu.2403653","article-title":"PI3-kinase\/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways","volume":"19","author":"Grandage","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2023.175957_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153442","article-title":"Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1\/2-mediated cofilin-1 phosphorylation","volume":"82","author":"Hsu","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2023.175957_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.05.045","article-title":"Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells","volume":"131","author":"Huang","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2023.175957_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9070633","article-title":"Targeting the MAPK\/ERK and PI3K\/AKT signaling pathways affects NRF2, trx and GSH antioxidant systems in leukemia cells","volume":"9","author":"Jasek-Gajda","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2023.175957_bib13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/annonc\/mdw015","article-title":"New drugs in acute myeloid leukemia","volume":"27","author":"Kadia","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2023.175957_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ejphar.2023.175957_bib15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/cncr.33477","article-title":"Acute myeloid leukemia: treatment and research outlook for 2021 and the MD Anderson approach","volume":"127","author":"Kantarjian","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2023.175957_bib16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41419-020-03144-y","article-title":"Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance","volume":"11","author":"Kapoor","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2023.175957_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95679","article-title":"Emerging therapies for acute myeloid leukemia: translating biology into the clinic","volume":"2","author":"Kavanagh","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2023.175957_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bjh.17746","article-title":"Updates on targeted therapies for acute myeloid leukaemia","volume":"196","author":"Kayser","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2023.175957_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jcmm.12749","article-title":"Killing cancer with platycodin D through multiple mechanisms","volume":"20","author":"Khan","year":"2016","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2023.175957_bib20","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/ijc.23442","article-title":"Platycodin D induces mitotic arrest in vitro, leading to endoreduplication, inhibition of proliferation and apoptosis in leukemia cells","volume":"122","author":"Kim","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2023.175957_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canlet.2007.11.010","article-title":"Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells","volume":"261","author":"Kim","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2023.175957_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2023.175957_bib23","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2006-02-003475","article-title":"Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia","volume":"108","author":"Kornblau","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175957_bib24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1878-0261.12966","article-title":"Platycodin D inhibits autophagy and increases glioblastoma cell death via LDLR upregulation","volume":"16","author":"Lee","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejphar.2023.175957_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5487\/TR.2011.27.4.217","article-title":"Single oral dose toxicity test of platycodin d, a saponin from platycodin radix in mice","volume":"27","author":"Lee","year":"2011","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.ejphar.2023.175957_bib26","article-title":"Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2023.175957_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2015.01.003","article-title":"Platycodin D triggers autophagy through activation of extracellular signal-regulated kinase in hepatocellular carcinoma HepG2 cells","volume":"749","author":"Li","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175957_bib28","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.7314\/APJCP.2014.15.4.1745","article-title":"Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells","volume":"15","author":"Li","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.ejphar.2023.175957_bib29","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/aps.2015.99","article-title":"Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells","volume":"36","author":"Li","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.175957_bib30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","article-title":"High-dose daunorubicin in older patients with acute myeloid leukemia","volume":"361","author":"Lowenberg","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2023.175957_bib31","article-title":"Combined anti-cancer effects of platycodin D and sorafenib on androgen-independent and PTEN-deficient prostate cancer","volume":"11","author":"Lu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2023.175957_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.taap.2014.09.009","article-title":"Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway","volume":"281","author":"Luan","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175957_bib33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2174\/138945010791320809","article-title":"Potential of plant-derived natural products in the treatment of leukemia and lymphoma","volume":"11","author":"Lucas","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2023.175957_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.175957_bib35","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2023.175957_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood.2020006765","article-title":"Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia","volume":"138","author":"Murali","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175957_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3746\/pnf.2014.19.2.059","article-title":"Platycosides from the roots of platycodon grandiflorum and their Health benefits","volume":"19","author":"Nyakudya","year":"2014","journal-title":"Prev Nutr Food Sci"},{"key":"10.1016\/j.ejphar.2023.175957_bib38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0092-8674(00)00196-3","article-title":"Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma","volume":"103","author":"Pacold","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2023.175957_bib39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/15384101.2017.1403689","article-title":"Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies","volume":"17","author":"Prabhu","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2023.175957_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","article-title":"Molecular biomarkers in acute myeloid leukemia","volume":"31","author":"Prada-Arismendy","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.ejphar.2023.175957_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clml.2019.03.015","article-title":"Oral MEK 1\/2 inhibitor trametinib in combination with AKT inhibitor GSK2141795 in patients with acute myeloid leukemia with ras mutations: a phase II study","volume":"19","author":"Ragon","year":"2019","journal-title":"Clin. Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.ejphar.2023.175957_bib42","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2023.175957_bib43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biopha.2008.08.001","article-title":"Implication of intracellular ROS formation, caspase-3 activation and Egr-1 induction in platycodon D-induced apoptosis of U937 human leukemia cells","volume":"63","author":"Shin","year":"2009","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2023.175957_bib44","doi-asserted-by":"crossref","first-page":"21411","DOI":"10.3390\/molecules191221411","article-title":"Effects of platycodin D on proliferation, apoptosis and PI3K\/Akt signal pathway of human glioma U251 cells","volume":"19","author":"Xu","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2023.175957_bib45","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","article-title":"Survival of acute myeloid leukemia cells requires PI3 kinase activation","volume":"102","author":"Xu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2023.175957_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.etap.2013.03.012","article-title":"Combination treatment with platycodin D and osthole inhibits cell proliferation and invasion in mammary carcinoma cell lines","volume":"36","author":"Ye","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175957_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1089\/jmf.2009.1226","article-title":"Platycodin D induces apoptosis in MCF-7 human breast cancer cells","volume":"13","author":"Yu","year":"2010","journal-title":"J. Med. Food"},{"key":"10.1016\/j.ejphar.2023.175957_bib48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1089\/jmf.2011.2024","article-title":"Platycodin D induces reactive oxygen species-mediated apoptosis signal-regulating kinase 1 activation and endoplasmic reticulum stress response in human breast cancer cells","volume":"15","author":"Yu","year":"2012","journal-title":"J. Med. Food"},{"key":"10.1016\/j.ejphar.2023.175957_bib49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jep.2015.01.052","article-title":"Platycodon grandiflorus - an ethnopharmacological, phytochemical and pharmacological review","volume":"164","author":"Zhang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2023.175957_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3892\/ol.2020.12174","article-title":"Effects of Platycodin D on apoptosis, migration, invasion and cell cycle arrest of gallbladder cancer cells","volume":"20","author":"Zhang","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejphar.2023.175957_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21934","article-title":"Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, suppresses the growth and invasion of human oral squamous cell carcinoma cells via the NF-kappaB pathway","volume":"31","author":"Zhang","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923004697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923004697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T17:18:56Z","timestamp":1728407936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923004697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":51,"alternative-id":["S0014299923004697"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175957","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platycodin D induces apoptotic cell death through PI3K\/AKT and MAPK\/ERK pathways and synergizes with venetoclax in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175957"}}